Association of Y chromosome AZF region microdeletions with recurrent miscarriage in Iranian couples: A case–control study
Molecular Genetics & Genomic Medicine · 2024
DOI: 10.1002/mgg3.2392 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2024. Verfasst von Nasrin Pazoki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Faculty of Biological Sciences, North Tehran Branch, Islamic Azad University, Tehran, Iran. Hauptthemen laut MEDLINE: Semen, Abortion, Habitual, Sex Chromosome Aberrations, Sex Chromosome Disorders of Sex Development. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Recent studies have linked recurrent pregnancy loss (RPL) to abnormalities in the sperm genome, specifically microdeletions in the azoospermia factor (AZF) region. This study investigated the potential association between Y chromosome microdeletions in the AZF region and RPL in Iranian couples.
Methods
The research presents a case–control study of 240 men: 120 whose partners experienced recurrent miscarriage, and 120 who had successful pregnancies without history of miscarriage. The study used semen parameters, hormone analyses, and microdeletion analysis via multiplex PCR and the YChromStrip kit. Thus, the sequence‐tagged site (STS) markers of AZFa (sY84, sY86), AZFb (sY127, sY134), and AZFc (sY254, sY255) regions were examined.
Results
The variations in semen parameters and sex hormone levels between cases and controls are suggest impaired testicular function in men whose partners had recurrent miscarriages ( p < 0.05). Furthermore, the study revealed a negative correlation between sperm count and follicle‐stimulating hormone (FSH) level, and a positive one between sperm motility and testosterone concentration. There were no microdeletions in the control group, while the RPL group showed 20 deletions in AZFb (sY134) (16.66%) and 10 deletions each in AZFb (sY127) (8.33%) and AZFc (sY254) (8.33%).
Conclusion
Microdeletions in sY134 (AZFb) were significantly associated with RPL in Iranian men ( p = 0.03). AZF microdeletion screening in couples with RPL can provide valuable information for ethnical genetic counseling and management of recurrent miscarriage. Further studies on larger populations or across various ethnic groups, conclusions and the inclusion of other factors like epigenetic changes explain the role of AZF microdeletions in RPL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Genetics, Faculty of Biological Sciences, North Tehran Branch, Islamic Azad University, Tehran, Iran.
- Department of Biology, Faculty of Biological Sciences, North Tehran Branch, Islamic Azad University, Tehran, Iran.
- Department of Cell and Molecular Biology, School of Biological Sciences, Kharazmi University, Tehran, Iran.
- Cellular and Molecular Biology Research Center, Larestan University of Medical Sciences, Larestan, Iran.
ORCID-Profile: Nasrin Pazoki, Mitra Salehi, Seyed Abdolhamid Angaji, Meghdad Abdollahpour-Alitappeh
Zitieren
APA
Pazoki, N., Salehi, M., Angaji, S. A., & Abdollahpour-Alitappeh, M. (2024). Association of Y chromosome AZF region microdeletions with recurrent miscarriage in Iranian couples: A case–control study. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.2392
Vancouver
Pazoki N, Salehi M, Angaji SA, Abdollahpour-Alitappeh M. Association of Y chromosome AZF region microdeletions with recurrent miscarriage in Iranian couples: A case–control study. Molecular Genetics & Genomic Medicine. 2024. doi:10.1002/mgg3.2392
BibTeX
@article{Pazoki2024,
author = {Pazoki, Nasrin and Salehi, Mitra and Angaji, Seyed Abdolhamid and Abdollahpour-Alitappeh, Meghdad},
title = {Association of Y chromosome AZF region microdeletions with recurrent miscarriage in Iranian couples: A case–control study},
journal = {Molecular Genetics & Genomic Medicine},
year = {2024},
doi = {10.1002/mgg3.2392}
}
EUVIMED